REducing the Risk of COgnitive DEcline ad Dementia in Patients With Subjective Cognitive Decline Through an Immersive Virtual Reality and Telemedicine-based Multi-component Intervention: the SCD-ReCODED Study
SCD-ReCODED
Preventing Cognitive Decline and Dementia Through an Innovative Immersive Virtual Reality and Telemedicine-based Multi-component Intervention: a Randomized Controlled Trial
1 other identifier
interventional
75
1 country
1
Brief Summary
Older adults with subjective cognitive decline (SCD) are at high risk of developing dementia and frequently experience subclinical symptoms (e.g., anxiety, depression) which are themselves associated with dementia and cognitive decline risk. To date, the lack of effective disease-modifying treatments, along with the reliable identification of modifiable lifestyle risk factors (e.g., cognitive activity, dietary habits, physical exercise), have led to growing interest to invest in non-pharmacological interventions that may reduce the prevalence and incidence of dementia and cognitive decline in older adults. In this framework, the aim of this project is to evaluate the efficacy of an Immersive Virtual Reality (IVR) and telemedicine-based multi-component intervention, combining cognitive training and a health and lifestyle education program, for preventing cognitive decline and dementia in at-risk individuals (i.e., SCD). For this purpose, a randomized, double-blinded controlled trial (RCT) will be conducted on seventy-five eligible individuals with SCD, who will be randomly assigned to one of three conditions: (a) multi-component intervention (MC-I), including SCD-tailored cognitive IVR training plus a health and lifestyle education program, (b) cognitive-only intervention (CO-I), including the SCD-tailored cognitive IVR training plus an active control for the education program, and (c) active control intervention (AC-I) for both cognitive training and education program. Intervention will be provided in 20 at-home sessions (4 sessions/week, each lasting about 30 minutes) over a period of 5 weeks. Outcome measures include clinical, neuropsychological, behavioural and neuroimaging data that will be collected before and immediately after intervention in order to detect potentially intervention-induced changes in objective cognitive functioning (primary outcome), subjective cognitive functioning, mood, quality of life and brain connectivity (secondary outcome). Users' compliance with IVR and telemedicine approach will be also evaluated, as well as individuals' factors affecting training efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 10, 2024
CompletedFirst Posted
Study publicly available on registry
May 24, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedOctober 1, 2024
September 1, 2024
10 months
May 10, 2024
September 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Cognitive functioning (1): change scores on the Face-Name Associative Memory Exam
The Face-Name Associative Memory Exam (short form - FNAME12) is an associative long-term memory task that requires the participant to learn and retrieve 12 novel face-name and face-occupation pairs. It consists of two learning phases, followed by an immediate cued recall and a 30-min delayed recall and recognition trial. For each trial, scores range from 0 to 12, where higher scores indicate better memory performance.
Baseline, post-intervention (around 6 weeks after baseline)
Cognitive functioning (2): change scores on the Visual Short-Term Memory Binding Test
The Visual Short-Term Memory Binding Test is a recognition task based on a change detection paradigm for arrays of stimuli presented on a computer screen. Two conditions are investigated, that is, a shape-only condition as the first and a shape-color condition as the second. In both conditions, participants are asked to remember visual arrays of two or three black polygons (in the shape-only condition) or colored polygons (in the shape-color condition) presented for 2 s (study phase). For each condition, scores range from 0 to 32, where higher scores indicate better memory performance.
Baseline, post-intervention (around 6 weeks after baseline)
Cognitive functioning (3): change scores on the Spatial pattern separation test
The Spatial pattern separation test assesses the ability to differentiate partially overlapping patterns of activation in order to retrieve one pattern as separate from others that are similar. Specifically, it consists of 36 trials, in which the participant is required to learn the location of a grey circle on a sceen; then the participant is required to recognize the position of the previously-learned grey circle with respect to a foil located either to the left or the right of the target. Scores range from 0 to 36, where higher scores indicate better memory performance.
Baseline, post-intervention (around 6 weeks after baseline)
Secondary Outcomes (6)
Transfer effect on self-perceived cognitive functioning: change scores on the Subjective Memory Complaints Questionnaire
Baseline, post-intervention (around 6 weeks after baseline)
Intervention-induced changes in whole-brain functional connectivity
Baseline, post-intervention (around 6 weeks after baseline)
Transfer effect on mood (1): change scores on the 30-item Geriatric Depression Scale
Baseline, post-intervention (around 6 weeks after baseline)
Transfer effect on mood (2): change scores on the State-Trait Anxiety Inventory
Baseline, post-intervention (around 6 weeks after baseline)
Transfer effect on mood (3): change scores on the 18-item Apathy Evaluation Scale (AES)
Baseline, post-intervention (around 6 weeks after baseline)
- +1 more secondary outcomes
Study Arms (3)
Multi-component Intervention (MC-I)
EXPERIMENTALVR cognitive training + Psychoeducation program
Cognitive-only intervention (CO-I)
ACTIVE COMPARATORVR Cognitive training + Psychoeducation active control
Active control intervention (AC-I)
ACTIVE COMPARATORVR Cognitive active control + Psychoeducation active control
Interventions
In a period of 5 consecutive weeks, participants will receive: * an interactive immersive virtual reality cognitive training for 30 minutes, 3 days per week. It consists in different tasks implemented in virtual real-like scenarios of daily living situations that target the following cognitive processes: long-term associative memory, relational binding, spatial pattern separation and pattern completion; * an interactive immersive virtual reality health and lifestyle education program for 30 minutes, 1 day per week. It consists in 360° videos aimed at advancing awareness and knowledge of the various health conditions associated with an increased risk of cognitive decline and dementia and helping participants to develop a healthier lifestyle.
In a period of 5 consecutive weeks, participants will receive: * the interactive immersive virtual reality cognitive training as described in the MC-I condition, for about 30 minutes, 3 days per week; * an active control of the immersive virtual reality psychoeducation program for 30 minutes, 1 day per week.
In a period of 5 consecutive weeks, participants will receive: * an active control of the immersive virtual reality cognitive training (participants will be requested to virtually carry out daily actions, in the same setting as those performed in cognitive immersive VR training, but they will follow prearranged instructions requiring very low cognitive demands) for about 30 minutes, 3 days per week; * an active control of the immersive virtual reality psychoeducation program for about 30 minutes, 1 day per week.
Eligibility Criteria
You may qualify if:
- Self-perceived decline in cognition compared to five years ago
- Lack of objective cognitive impairment.
You may not qualify if:
- Clinically significant depression and anxiety;
- Psychiatric disorders;
- Unstable medical conditions.
- Severe visual, auditory, verbal or physical impairments interfere with communication, command compliance, and strategy execution
- Dizziness or epilepsy history;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
I.R.C.C.S Santa Lucia Foundation
Rome, Lazio, 00179, Italy
Related Publications (1)
De Simone MS, Zabberoni S, Costa A, Tenaglia E, Tieri G. The effects of an immersive virtual reality and telemedicine-based multi-component intervention in individuals with subjective cognitive decline: study protocol of a randomized controlled trial. Front Psychol. 2025 Jul 11;16:1591239. doi: 10.3389/fpsyg.2025.1591239. eCollection 2025.
PMID: 40718565DERIVED
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
May 10, 2024
First Posted
May 24, 2024
Study Start
July 1, 2024
Primary Completion
May 1, 2025
Study Completion
December 1, 2025
Last Updated
October 1, 2024
Record last verified: 2024-09